Allyl bromide → HCID 57418747, compound

HRID 1715576Notes

Reaction equation

HRID 1715576 reaction equation
[Br:1][C:2]1[CH:3]=[C:4]2[C:8](=[CH:9][CH:10]=1)[NH:7][N:6]=[CH:5]2.[CH2:11](Br)[CH:12]=[CH2:13].C(=O)([O-])[O-].[K+].[K+]>CN(C=O)C>[CH2:13]([N:7]1[C:8]2[C:4](=[CH:3][C:2]([Br:1])=[CH:10][CH:9]=2)[CH:5]=[N:6]1)[CH:12]=[CH2:11]

Participants

5

Procedure

5-Bromoindazole (Bioorg. Med. Chem. Lett., 11:1153-1156 (2001)) (3.94 g, 20.0 mmol), allyl bromide (2.6 mL, 30 mmol) and potassium carbonate (4.15 g, 30.0 mmol) were heated in DMF (25 mL) at 100° C. for 18 hours. The reaction was cooled, filtered through celite, and the solids were washed with EtOAc. The solution was concentrated to near dryness and then partitioned between EtOAc and water. The organic phase was washed with NaHCO3, dried (MgSO4), concentrated, and purified by column chromatography (silica gel, 7% EtOAc/hexanes) to provide the N1 isomer (faster eluting) 1-allyl-5-bromo-1H-indazole (is) (1.7 g, 36% yield). 1H NMR (400 MHz, CDCl3) δ 7.95 (s, 1H), 7.88 (d, J=2.3 Hz, 1H), 7.44 (dd, J=8.6, 1.6 Hz, 1H), 7.29 (d, J=8.6 Hz, 1H), 6.06-5.97 (m, 1H), 5.24 (dd, J=10.2, 1.6 Hz, 1H), 5.12 (d, J=16.4 Hz, 1H), 5.01-5.00 (m, 2H); MS (ESI+) m/z 237, 239 (M+H, Br pattern) detected; HPLC (5 to 95%) 2.98 min.

Workup

  1. temperatureThe reaction was cooled
  2. filtrationfiltered through celite
  3. washthe solids were washed with EtOAc
  4. concentrationThe solution was concentrated
  5. custompartitioned between EtOAc and water
  6. washThe organic phase was washed with NaHCO3
  7. dry with materialdried (MgSO4)
  8. concentrationconcentrated
  9. custompurified by column chromatography (silica gel, 7% EtOAc/hexanes)
  10. customto provide the N1 isomer (

Sources & evidence

ORD record
ord-dc17142ce1c64eccbe8d7a642f6c4515
Source dataset
uspto-grants-2010_09
Patent number
US07799782B2

Reaction notes

Loading…